CLIC2

gene
On this page

Also known as XAP121CLCNL2

Summary

CLIC2 (CLIC family member 2, HGNC:2063) is a protein-coding gene on chromosome Xq28, encoding Chloride intracellular channel protein 2 (O15247). In the soluble state, catalyzes glutaredoxin-like thiol disulfide exchange reactions with reduced glutathione as electron donor.

This gene encodes a chloride intracellular channel protein. Chloride channels are a diverse group of proteins that regulate fundamental cellular processes including stabilization of cell membrane potential, transepithelial transport, maintenance of intracellular pH, and regulation of cell volume. This protein plays a role in inhibiting the function of ryanodine receptor 2. A mutation in this gene is the cause of an X-linked form of cognitive disability.

Source: NCBI Gene 1193 — RefSeq curated summary.

At a glance

  • Gene–disease (curated): X-linked intellectual disability-cardiomegaly-congestive heart failure syndrome (Moderate, GenCC) — +1 more curated relationship
  • Clinical variants (ClinVar): 95 total — 1 likely-pathogenic
  • Phenotypes (HPO): 30
  • MANE Select transcript: NM_001289

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:2063
Approved symbolCLIC2
NameCLIC family member 2
LocationXq28
Locus typegene with protein product
StatusApproved
AliasesXAP121, CLCNL2
Ensembl geneENSG00000155962
Ensembl biotypeprotein_coding
OMIM300138
Entrez1193

Gene structure

Transcript identifiers

Ensembl transcripts: 5 — 3 protein_coding, 2 protein_coding_CDS_not_defined

ENST00000321926, ENST00000369449, ENST00000465553, ENST00000491205, ENST00000948941

RefSeq mRNA: 1 — MANE Select: NM_001289 NM_001289

CCDS: CCDS14767

Canonical transcript exons

ENST00000369449 — 6 exons

ExonStartEnd
ENSE00001847718155276211155278064
ENSE00001890277155334371155334614
ENSE00003459873155279962155280068
ENSE00003518869155298785155298910
ENSE00003545471155299036155299145
ENSE00003567274155279149155279330

Expression profiles

Bgee: expression breadth ubiquitous, 232 present calls, max score 93.46.

FANTOM5 (CAGE): breadth broad, TPM avg 7.9582 / max 541.5667, expressed in 688 samples.

FANTOM5 promoters (3 alternative TSS)

Promoter IDTPM avgSamples expressed
2010865.1044630
2010842.7854451
2010850.068427

Top tissues by expression

283 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
calcaneal tendonUBERON:000370193.46gold quality
colonic epitheliumUBERON:000039790.39gold quality
right lungUBERON:000216790.03gold quality
spleenUBERON:000210689.22gold quality
upper lobe of left lungUBERON:000895289.22gold quality
gall bladderUBERON:000211089.17gold quality
superficial temporal arteryUBERON:000161489.14gold quality
upper lobe of lungUBERON:000894889.08gold quality
lymph nodeUBERON:000002989.05gold quality
left lobe of thyroid glandUBERON:000112088.94gold quality
thyroid glandUBERON:000204688.62gold quality
right lobe of thyroid glandUBERON:000111988.43gold quality
omental fat padUBERON:001041487.69gold quality
peritoneumUBERON:000235887.62gold quality
subcutaneous adipose tissueUBERON:000219086.87gold quality
lungUBERON:000204886.78gold quality
adipose tissue of abdominal regionUBERON:000780886.74gold quality
lower lobe of lungUBERON:000894986.72gold quality
tendonUBERON:000004384.98gold quality
rectumUBERON:000105284.93gold quality
vermiform appendixUBERON:000115484.78gold quality
skin of hipUBERON:000155484.70gold quality
pericardiumUBERON:000240784.59gold quality
endocervixUBERON:000045883.68gold quality
adipose tissueUBERON:000101383.64gold quality
connective tissueUBERON:000238483.40gold quality
smooth muscle tissueUBERON:000113583.35gold quality
body of uterusUBERON:000985383.10gold quality
left ovaryUBERON:000211982.87gold quality
mucosa of stomachUBERON:000119982.52gold quality

Single-cell (SCXA)

Detected in 8 experiment(s), a significant marker in 8.

ExperimentMarker?Max mean expression
E-GEOD-86618yes404.20
E-MTAB-8142yes120.22
E-HCAD-11yes38.12
E-ANND-3yes22.63
E-MTAB-8498yes10.12
E-GEOD-135922yes9.68
E-MTAB-6678yes7.26
E-MTAB-5061yes6.40

Regulation

Is transcription factor: no

Upstream regulators (CollecTRI, top): STAT1, ZNF804A

miRNA regulators (miRDB)

76 targeting CLIC2, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-4776-3P100.0068.731340
HSA-MIR-4795-3P100.0074.624024
HSA-MIR-4510100.0066.602050
HSA-MIR-6127100.0066.762188
HSA-MIR-6129100.0066.462080
HSA-MIR-6130100.0066.692012
HSA-MIR-6133100.0066.482064
HSA-MIR-8485100.0077.574731
HSA-MIR-5011-5P100.0083.465820
HSA-MIR-126-5P100.0072.713180
HSA-MIR-428299.9975.366408
HSA-MIR-548C-3P99.9974.017587
HSA-MIR-569699.9872.364487
HSA-MIR-3692-3P99.9870.272139
HSA-MIR-302C-5P99.9772.563642
HSA-MIR-60799.9773.625593
HSA-MIR-3688-3P99.9772.022834
HSA-MIR-493-5P99.9672.472382
HSA-LET-7C-3P99.9573.422862
HSA-MIR-335-3P99.9373.364958
HSA-MIR-4778-3P99.9370.401818
HSA-MIR-6809-3P99.9171.453814
HSA-MIR-4753-3P99.9071.033786
HSA-LET-7A-2-3P99.8770.531921
HSA-MIR-579-3P99.8671.663628
HSA-MIR-221-3P99.8671.561329
HSA-MIR-222-3P99.8671.351337
HSA-MIR-5003-3P99.8569.292517
HSA-LET-7G-3P99.8570.431929
HSA-MIR-576-5P99.8470.462582

Literature-anchored findings (GeneRIF, showing 7)

  • CLIC2 inhibited cardiac ryanodine receptor Ca2+ release channels in lipid bilayers when added to the cytoplasmic side of the channels and inhibited Ca2+ release from cardiac sarcoplasmic reticulum vesicles (PMID:15147738)
  • CLIC2 forms pH-dependent chloride channels in vitro with higher channel activity at low pH levels and that the channels are subject to redox regulation (PMID:17945253)
  • Human CLIC2 was crystallized in 2 different forms, in presence of GSSH. Form A displayed P2(1)2(1)2(1) symmetry, with unit-cell parameters a=44.0, b=74.7, c=79.8 A. Form B displayed P2(1) symmetry, with unit-cell parameters a=36.0, b=66.9, c=44.1 A. (PMID:18007051)
  • crystal structure of soluble human CICL2 and implications for function (PMID:18186468)
  • a vital role for the CLIC2 protein in maintaining normal cognitive function via its interaction with RyRs in the brain. (PMID:22814392)
  • We have determined the crystal structure of soluble Clic2 from the euryhaline teleost fish Oreochromis mossambicus. Structural comparison of tilapia and human CLIC2 with other CLICs shows that these proteins are highly conserved. (PMID:29198705)
  • Chloride intracellular channel protein 2 is secreted and inhibits MMP14 activity, while preventing tumor cell invasion and metastasis. (PMID:34229297)

Cross-species orthologs

33 orthologs

OrganismSymbolGene ID
danio_rerioclic2ENSDARG00000010625
rattus_norvegicusClic2ENSRNOG00000000728
drosophila_melanogasterGstD1FBGN0001149
drosophila_melanogasterGstD2FBGN0010038
drosophila_melanogasterGstD3FBGN0010039
drosophila_melanogasterGstD4FBGN0010040
drosophila_melanogasterGstD5FBGN0010041
drosophila_melanogasterGstD6FBGN0010042
drosophila_melanogasterGstD7FBGN0010043
drosophila_melanogasterGstD8FBGN0010044
drosophila_melanogasterGstE12FBGN0027590
drosophila_melanogasterClicFBGN0030529
drosophila_melanogasterGstT3FBGN0031117
drosophila_melanogasterGstE13FBGN0033381
drosophila_melanogasterGstE1FBGN0034335
drosophila_melanogasterGstE11FBGN0034354
drosophila_melanogasterGstD9FBGN0038020
drosophila_melanogasterGstD10FBGN0042206
drosophila_melanogasterGstT1FBGN0050000
drosophila_melanogasterGstT2FBGN0050005
drosophila_melanogasterGstE9FBGN0063491
drosophila_melanogasterGstE8FBGN0063492
drosophila_melanogasterGstE7FBGN0063493
drosophila_melanogasterGstE6FBGN0063494
drosophila_melanogasterGstE5FBGN0063495
drosophila_melanogasterGstE4FBGN0063496
drosophila_melanogasterGstE3FBGN0063497
drosophila_melanogasterGstE2FBGN0063498
drosophila_melanogasterGstE10FBGN0063499
caenorhabditis_elegansexc-4WBGENE00001365
caenorhabditis_elegansWBGENE00001371
caenorhabditis_elegansgst-43WBGENE00001791
caenorhabditis_elegansWBGENE00021817

Paralogs (14): GSTO2 (ENSG00000065621), GSTT2 (ENSG00000099984), GSTZ1 (ENSG00000100577), GDAP1 (ENSG00000104381), CLIC5 (ENSG00000112782), GDAP1L1 (ENSG00000124194), GSTT2B (ENSG00000133433), GSTO1 (ENSG00000148834), CLIC6 (ENSG00000159212), CLIC4 (ENSG00000169504), CLIC3 (ENSG00000169583), CLIC1 (ENSG00000213719), EEF1G (ENSG00000254772), GSTT4 (ENSG00000276950)

Protein

Protein identifiers

Chloride intracellular channel protein 2O15247 (reviewed: O15247)

Alternative names: Glutaredoxin-like oxidoreductase CLIC2, Glutaredoxin-like peroxidase CLIC2, XAP121

All UniProt accessions (2): O15247, A6PVS0

UniProt curated annotations — full annotation on UniProt →

Function. In the soluble state, catalyzes glutaredoxin-like thiol disulfide exchange reactions with reduced glutathione as electron donor. Displays weak glutathione peroxidase activity. Can insert into membranes and form chloride ion channels. Membrane insertion seems to be redox-regulated and may occur only under oxidizing conditions. Modulates the activity of RYR2 and inhibits calcium influx.

Subunit / interactions. Monomer. Interacts with TRAPPC2 and RYR2.

Subcellular location. Cytoplasm. Membrane.

Tissue specificity. Expressed in adult and fetal brain, heart, skeletal muscle, liver, lung, and spleen. Detected in adult stomach and testis. Expressed in fetal thymus and kidney.

Activity regulation. The channel conductance is regulated by pH.

Domain organisation. Members of this family may change from a globular, soluble state to a state where the N-terminal domain is inserted into the membrane and functions as a chloride channel. The redox status of the active cysteine in Cys-X-X-Cys motif likely determines the capacity to adopt a soluble or membrane-inserted state. A conformation change of the N-terminal domain is thought to expose hydrophobic surfaces that trigger membrane insertion. The active G-site has a dithiol Cys-X-X-Cys motif which mediates glutathione-dependent redox catalysis.

Similarity. Belongs to the chloride channel CLIC family.

RefSeq proteins (1): NP_001280* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR002946CLICFamily
IPR010987Glutathione-S-Trfase_C-likeDomain
IPR030253GST_C_CLIC-2Domain
IPR036249Thioredoxin-like_sfHomologous_superfamily
IPR036282Glutathione-S-Trfase_C_sfHomologous_superfamily
IPR040079Glutathione_S-TrfaseFamily
IPR053823CLIC_NDomain

Pfam: PF13410, PF22441

Catalyzed reactions (Rhea), 3 shown:

  • chloride(in) = chloride(out) (RHEA:29823)
  • tert-butyl hydroperoxide + 2 glutathione = tert-butanol + glutathione disulfide + H2O (RHEA:69412)
  • cumene hydroperoxide + 2 glutathione = 2-phenylpropan-2-ol + glutathione disulfide + H2O (RHEA:69651)

UniProt features (38 total): helix 11, strand 8, region of interest 5, turn 4, binding site 2, sequence conflict 2, chain 1, transmembrane region 1, disulfide bond 1, sequence variant 1, domain 1, short sequence motif 1

Structure

Experimental structures (PDB)

3 structures.

PDBMethodResolution (Å)
2R4VX-RAY DIFFRACTION1.85
2R5GX-RAY DIFFRACTION1.86
2PERX-RAY DIFFRACTION2

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-O15247-F193.280.85

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Ligand- & substrate-binding residues (2): 227; 25

Disulfide bonds (1): 30–33

Function

Pathways and Gene Ontology

Reactome pathways

2 pathways

IDPathway
R-HSA-2672351Stimuli-sensing channels
R-HSA-5578775Ion homeostasis

MSigDB gene sets: 285 (showing top): WALLACE_PROSTATE_CANCER_RACE_UP, GOBP_CIRCULATORY_SYSTEM_PROCESS, GOBP_INORGANIC_ANION_TRANSPORT, GOBP_REGULATION_OF_CARDIAC_MUSCLE_CONTRACTION_BY_REGULATION_OF_THE_RELEASE_OF_SEQUESTERED_CALCIUM_ION, GOMF_GLUTATHIONE_TRANSFERASE_ACTIVITY, GOBP_MONOATOMIC_CATION_TRANSPORT, GNF2_ANK1, YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_DN, GOBP_REGULATION_OF_STRIATED_MUSCLE_CONTRACTION, GOBP_REGULATION_OF_MUSCLE_CONTRACTION, GOBP_CHLORIDE_TRANSPORT, GOBP_MUSCLE_CONTRACTION, RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP, GOBP_REGULATION_OF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORT, GOBP_CELLULAR_RESPONSE_TO_TOXIC_SUBSTANCE

GO Biological Process (9): chloride transport (GO:0006821), signal transduction (GO:0007165), regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880), regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881), monoatomic ion transport (GO:0006811), monoatomic ion transmembrane transport (GO:0034220), negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315), cellular oxidant detoxification (GO:0098869), chloride transmembrane transport (GO:1902476)

GO Molecular Function (4): glutathione peroxidase activity (GO:0004602), chloride channel activity (GO:0005254), protein binding (GO:0005515), oxidoreductase activity (GO:0016491)

GO Cellular Component (8): nucleus (GO:0005634), nucleoplasm (GO:0005654), cytoplasm (GO:0005737), cytosol (GO:0005829), plasma membrane (GO:0005886), membrane (GO:0016020), chloride channel complex (GO:0034707), monoatomic ion channel complex (GO:0034702)

Reactome top-level categories

Rollup of top-2 pathways:

CategoryPathways
Ion channel transport1
Cardiac conduction1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular anatomical structure4
monoatomic anion transport1
inorganic anion transport1
cell communication1
cellular process1
signaling1
regulation of cellular process1
cellular response to stimulus1
release of sequestered calcium ion into cytosol by sarcoplasmic reticulum1
regulation of release of sequestered calcium ion into cytosol1
regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum1
regulation of cardiac muscle contraction by calcium ion signaling1
transport1
monoatomic ion transport1
transmembrane transport1
ryanodine-sensitive calcium-release channel activity1
negative regulation of release of sequestered calcium ion into cytosol1
regulation of ryanodine-sensitive calcium-release channel activity1
negative regulation of calcium ion transmembrane transporter activity1
cellular detoxification1
chloride transport1
monoatomic anion transmembrane transport1
peroxidase activity1
monoatomic anion channel activity1
chloride transmembrane transporter activity1
binding1
catalytic activity1
intracellular membrane-bounded organelle1
nuclear lumen1
intracellular anatomical structure1
cytoplasm1
membrane1
cell periphery1
monoatomic ion channel complex1
transmembrane transporter complex1

Protein interactions and networks

STRING

882 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
CLIC2MAPK15Q8TD08828
CLIC2PHC3Q8NDX5749
CLIC2TRDNQ13061557
CLIC2RAB39BQ96DA2520
CLIC2ASPHQ12797474
CLIC2TRAK2O60296473
CLIC2EZRP15311458
CLIC2PIN4Q9Y237444
CLIC2CAV1Q03135437
CLIC2RYR2Q92736431
CLIC2MT-CO1P00395423
CLIC2TMLHEQ9NVH6420
CLIC2FAM229BQ4G0N7420
CLIC2FUNDC2Q9BWH2420
CLIC2VBP1P61758419

IntAct

15 interactions, top by confidence:

ABTypeScore
CLIC2TPRNpsi-mi:“MI:0915”(physical association)0.560
CLIC4CLIC2psi-mi:“MI:0914”(association)0.530
CLIC5CLIC2psi-mi:“MI:0914”(association)0.350
C15orf40CLIC2psi-mi:“MI:0914”(association)0.350
RPL35CLIC2psi-mi:“MI:0914”(association)0.350
RPP14CLIC2psi-mi:“MI:0914”(association)0.350
TXNDC17CLIC2psi-mi:“MI:0914”(association)0.350
SAP30CLIC2psi-mi:“MI:0914”(association)0.350
CLIC2TPRNpsi-mi:“MI:0914”(association)0.350
FN1ESYT2psi-mi:“MI:0914”(association)0.350
CLIC2TPRNpsi-mi:“MI:0915”(physical association)0.000

BioGRID (25): CLIC2 (Affinity Capture-MS), CLIC2 (Affinity Capture-MS), CLIC2 (Affinity Capture-MS), CLIC2 (Affinity Capture-MS), CLIC2 (Two-hybrid), TPRN (Two-hybrid), CLIC2 (Affinity Capture-MS), TPRN (Affinity Capture-MS), CLIC2 (Affinity Capture-MS), SBDS (Affinity Capture-MS), CLIC2 (Affinity Capture-MS), CLIC2 (Affinity Capture-MS), CLIC2 (Affinity Capture-MS), CLIC2 (Affinity Capture-MS), CLIC2 (Affinity Capture-MS)

ESM2 similar proteins: A0A1L5BUX8, A0A1U8QXK4, A0A1U9YI21, B5BP46, C8VQ63, D4Z909, M1W426, O00299, O04487, O15247, O45405, O74830, P12261, P21161, P26642, P30111, P34345, P36008, P40921, P42936, P43387, Q00717, Q4WB03, Q5E9B7, Q5M883, Q5R957, Q5Z627, Q6MG61, Q6NMS0, Q6YW46, Q8BXK9, Q8WQA4, Q91375, Q95MF9, Q9CA57, Q9CAS6, Q9EPT8, Q9FUM1, Q9FUS6, Q9FUT0

Diamond homologs: O00299, O15247, O95833, P35526, Q29238, Q5E9B7, Q5M883, Q5R957, Q6MG61, Q811Q2, Q8BHB9, Q8BXK9, Q95MF9, Q96NY7, Q9D7P7, Q9EPT8, Q9N2G5, Q9NZA1, Q9QYB1, Q9XSA7, Q9Y696, Q9Z0W7, Q9Z1Q5, O45405, Q9VY78, P81124, Q9FRL8, Q8WQA4

SIGNOR signaling

1 interactions.

AEffectBMechanism
ZNF804A“down-regulates quantity by repression”CLIC2“transcriptional regulation”

Disease & clinical

Clinical variants and AI predictions

ClinVar

95 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic1
Uncertain significance37
Likely benign8
Benign6

Top pathogenic / likely-pathogenic (1)

Variant IDHGVSClassification
1808688GRCh37/hg19 Xq28(chrX:154502832-154633634)x4Likely pathogenic

SpliceAI

589 predictions. Top by Δscore:

VariantEffectΔscore
X:155278060:GCAAC:Gacceptor_gain1.0000
X:155278061:CAAC:Cacceptor_gain1.0000
X:155278061:CAACC:Cacceptor_gain1.0000
X:155278062:AAC:Aacceptor_gain1.0000
X:155278063:AC:Aacceptor_gain1.0000
X:155278064:CC:Cacceptor_gain1.0000
X:155278064:CCTA:Cacceptor_loss1.0000
X:155278065:C:CAacceptor_loss1.0000
X:155278065:C:CCacceptor_gain1.0000
X:155278070:A:ACacceptor_gain1.0000
X:155278071:T:Cacceptor_gain1.0000
X:155278071:T:TCacceptor_gain1.0000
X:155278072:T:Cacceptor_gain1.0000
X:155278072:T:TCacceptor_gain1.0000
X:155278073:T:Cacceptor_gain1.0000
X:155278073:T:TCacceptor_gain1.0000
X:155278076:C:CTacceptor_gain1.0000
X:155278077:A:Tacceptor_gain1.0000
X:155279145:TTAC:Tdonor_loss1.0000
X:155279147:A:ACdonor_gain1.0000
X:155279147:ACT:Adonor_loss1.0000
X:155279148:C:CAdonor_gain1.0000
X:155279148:CT:Cdonor_gain1.0000
X:155279148:CTT:Cdonor_gain1.0000
X:155279148:CTTT:Cdonor_gain1.0000
X:155279148:CTTTA:Cdonor_gain1.0000
X:155279326:AAAAT:Aacceptor_gain1.0000
X:155279327:AAAT:Aacceptor_gain1.0000
X:155279328:AAT:Aacceptor_gain1.0000
X:155279329:AT:Aacceptor_gain1.0000

AlphaMissense

1637 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
X:155277972:A:CF225L0.999
X:155277972:A:TF225L0.999
X:155277974:A:GF225L0.999
X:155279162:A:GL190P0.999
X:155279179:A:CC184W0.999
X:155279181:A:GC184R0.999
X:155279294:A:GL146P0.999
X:155280002:A:CF120L0.999
X:155280002:A:TF120L0.999
X:155280003:A:GF120S0.999
X:155280004:A:GF120L0.999
X:155280011:A:CF117L0.999
X:155280011:A:TF117L0.999
X:155280012:A:CF117C0.999
X:155280013:A:GF117L0.999
X:155298809:A:GL90S0.999
X:155298862:G:CF72L0.999
X:155298862:G:TF72L0.999
X:155298864:A:GF72L0.999
X:155298866:G:TP71Q0.999
X:155298867:G:AP71S0.999
X:155299062:A:CF47L0.999
X:155299062:A:TF47L0.999
X:155299063:A:GF47S0.999
X:155299064:A:GF47L0.999
X:155299074:T:AK43N0.999
X:155299074:T:GK43N0.999
X:155299075:T:AK43I0.999
X:155299092:G:CF37L0.999
X:155299092:G:TF37L0.999

dbSNP variants (sampled 300 via entrez): RS1000195252 (X:155275753 C>T), RS1000301853 (X:155285355 T>C), RS1000520478 (X:155310833 C>A), RS1000986289 (X:155328370 T>G), RS1001001769 (X:155319804 C>T), RS1001057917 (X:155310486 C>T), RS1001096762 (X:155319442 G>C,T), RS1001206498 (X:155306774 C>A), RS1001223601 (X:155292631 G>A,T), RS1001656943 (X:155323399 T>C), RS1001700165 (X:155306272 G>A), RS1001958712 (X:155323802 A>T), RS1002042885 (X:155334590 C>T), RS1002230923 (X:155293855 G>T), RS1002409743 (X:155282668 C>T)

Disease associations

OMIM: gene MIM:300138 | disease phenotypes: MIM:300886

GenCC curated gene-disease

DiseaseClassificationInheritance
X-linked intellectual disability-cardiomegaly-congestive heart failure syndromeModerateX-linked
X-linked complex neurodevelopmental disorderDisputed EvidenceX-linked

ClinGen Gene-Disease Validity (1)

Expert-panel classifications — Definitive > Strong > Moderate > Limited > Disputed > Refuted.

DiseaseClassificationInheritance
X-linked complex neurodevelopmental disorderDisputedXL

Mondo (2): X-linked intellectual disability-cardiomegaly-congestive heart failure syndrome (MONDO:0010473), X-linked complex neurodevelopmental disorder (MONDO:0100148)

Orphanet (1): X-linked intellectual disability-cardiomegaly-congestive heart failure syndrome (Orphanet:324410)

HPO phenotypes

30 total (30 of 30 shown, HPO-id order):

HPOTerm
HP:0000053Macroorchidism
HP:0000232Everted lower lip vermilion
HP:0000280Coarse facial features
HP:0000303Mandibular prognathia
HP:0000319Smooth philtrum
HP:0000396Overfolded helix
HP:0000400Macrotia
HP:0000414Bulbous nose
HP:0000426Prominent nasal bridge
HP:0001172Abnormal thumb morphology
HP:0001250Seizure
HP:0001263Global developmental delay
HP:0001344Absent speech
HP:0001634Mitral valve prolapse
HP:0001635Congestive heart failure
HP:0001640Cardiomegaly
HP:0001650Aortic valve stenosis
HP:0001653Mitral regurgitation
HP:0002187Profound intellectual disability
HP:0002465Poor speech
HP:0002510Spastic tetraplegia
HP:0002540Inability to walk
HP:0002751Kyphoscoliosis
HP:0003376Steppage gait
HP:0004749Atrial flutter
HP:0005180Tricuspid regurgitation
HP:0005280Depressed nasal bridge
HP:0005781Contractures of the large joints
HP:0006705Abnormal atrioventricular valve morphology
HP:0010808Protruding tongue

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

26 total (human), top 26 by PubMed support.

ChemicalActions (top 5)PubMed papers
sodium arsenitedecreases methylation, increases expression3
bisphenol Adecreases expression, increases expression2
Arsenic Trioxideincreases expression2
2,5,2’,5’-tetrachlorobiphenyldecreases expression1
decabromobiphenyl etherdecreases expression1
tetrabromobisphenol Adecreases expression1
CGP 52608affects binding, increases reaction1
2-palmitoylglycerolincreases expression1
2,2’,4,4’-tetrabromodiphenyl etherdecreases expression1
pentabrominated diphenyl ether 100increases expression1
hexabrominated diphenyl ether 153increases expression1
Air Pollutantsdecreases expression, increases abundance1
Benzo(a)pyrenedecreases methylation1
Dichlorodiphenyl Dichloroethylenedecreases expression1
Demecolcineincreases expression1
Estradiolaffects cotreatment, decreases expression1
Ethyl Methanesulfonateincreases expression1
Formaldehydeincreases expression1
Methyl Methanesulfonateincreases expression1
Progesteroneaffects cotreatment, decreases expression1
Silicon Dioxideincreases expression1
Smokedecreases expression, increases abundance1
Vincristineincreases expression1
Cyclosporineincreases expression1
Aflatoxin B1affects expression1
Antirheumatic Agentsdecreases expression1

Cellosaurus cell lines

1 cell lines: 1 transformed cell line

First 10 cell lines (id-ordered, not curated):

CellosaurusNameCategorySex
CVCL_YA41IDG-HEK293T-CLIC2-V5-OETransformed cell lineFemale

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.